Evidence Suggesting That Alzheimer's Disease May Be a Transmissible Disorder

被引:0
作者
Saw, Genevieve [1 ]
Yi, Ling-Xiao [1 ]
Tan, Eng King [1 ,2 ,3 ]
Zhou, Zhi Dong [1 ,3 ]
机构
[1] Natl Neurosci Inst, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore
[2] Singapore Gen Hosp, Dept Neurol, Outram Rd, Singapore 169608, Singapore
[3] Duke NUS Med Sch, Signature Res Program Neurosci & Behav Disorders, 8 Coll Rd, Singapore 169857, Singapore
基金
英国医学研究理事会;
关键词
Alzheimer's disease; transmissible disease; protein aggregation; neurodegeneration; pathogenesis; therapeutic strategies; CREUTZFELDT-JAKOB-DISEASE; DURA-MATER; BETA DEPOSITION; PATHOLOGY; ACCUMULATION; TAUOPATHY; TAU;
D O I
10.3390/ijms26020508
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is characterised by progressive neurodegeneration with the formation of amyloid beta (A beta) plaques and neurofibrillary tau tangles in the brain parenchyma. The causes of AD have been attributed to a combination of age-related changes within the brain as well as genetic, environmental and lifestyle factors. However, a recent study by Banerjee et al. highlights the possibility that AD may be a transmissible disease and that iatrogenic AD could be environmentally acquired, similar to iatrogenic Creutzfeldt-Jakob disease (iCJD). The study reports that contaminated A beta in cadaver-derived pituitary growth hormone (c-hGH) therapy, which patients received during childhood inoculation, may accidentally transmit into their brains, triggering neurodegeneration and AD onset in older age. Furthermore, corroborating evidence from various animal model studies and human case reports suggests that AD can be potentially transmissible.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Alzheimer's disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence
    Mancuso, Cesare
    Santangelo, Rosaria
    PHARMACOLOGICAL RESEARCH, 2018, 129 : 329 - 336
  • [22] Is Alzheimer's Disease a synaptic disorder?
    Pomponi, Massimiliano
    Bria, Pietro
    Pomponi, Massimo
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 13 (01) : 39 - 47
  • [23] Alzheimer's disease as a metabolic disorder
    Bloom, George S.
    Norambuena, Andres
    OCL-OILSEEDS AND FATS CROPS AND LIPIDS, 2018, 25 (04)
  • [24] Alzheimer's disease
    Lane, C. A.
    Hardy, J.
    Schott, J. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (01) : 59 - 70
  • [26] The Immunopathy of Alzheimer's Disease: Innate or Adaptive?
    Weaver, Donald F.
    CURRENT ALZHEIMER RESEARCH, 2023, 20 (02) : 63 - 70
  • [27] Review on pathogenesis and treatment of Alzheimer's disease
    Cai, Jinxia
    Liu, Yanqing
    Fan, Haojun
    DEVELOPMENTAL DYNAMICS, 2024, : 296 - 309
  • [28] Advances in Alzheimer's Disease Drug Development
    Rafii, Michael S.
    Aisen, Paul S.
    BMC MEDICINE, 2015, 13
  • [29] Evolutional Aspects of Alzheimer's Disease Pathogenesis
    Braak, Heiko
    Del Tredici, Kelly
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 : S155 - S161
  • [30] Amyloid β oligomers (AβOs) in Alzheimer's disease
    Mroczko, Barbara
    Groblewska, Magdalena
    Litman-Zawadzka, Ala
    Kornhuber, Johannes
    Lewczuk, Piotr
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (02) : 177 - 191